Purpose of review
The purpose of this study is to showcase advances in molecular imaging
of atheroma biology in living individuals.
Recent findings 18
F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) continues to be the predominant molecular imaging
approach for clinical applications, particularly in the large arterial beds. Recently, there has been significant progress in imaging of neovascularization
to delineate high-risk atheroma and to evaluate drug efficacy. In addition, new hardware detection technology and imaging agents are enabling in-vivo imaging of new targets on diverse imaging platforms.
In this review, we present recent exciting developments in molecular and structural imaging of atherosclerotic plaque inflammation
. Building upon prior studies, these advances develop key technology that will play an important role in propelling new diagnostic and therapeutic strategies identifying high-risk plaque phenotypes and assessing new plaque stabilization therapies in clinical trials.